IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ZUCCATO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.257
NA - Nord America 4.690
AS - Asia 4.500
SA - Sud America 480
AF - Africa 79
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.515
CN - Cina 1.691
GB - Regno Unito 1.452
IT - Italia 1.215
SG - Singapore 1.210
DE - Germania 736
HK - Hong Kong 443
SE - Svezia 395
BR - Brasile 362
RU - Federazione Russa 352
IN - India 231
FR - Francia 228
VN - Vietnam 224
BD - Bangladesh 152
NL - Olanda 151
UA - Ucraina 151
KR - Corea 141
FI - Finlandia 139
CA - Canada 135
TR - Turchia 134
IE - Irlanda 108
DK - Danimarca 61
JP - Giappone 60
EU - Europa 53
ID - Indonesia 50
BE - Belgio 41
ES - Italia 39
AU - Australia 37
CO - Colombia 35
GR - Grecia 35
CH - Svizzera 25
NO - Norvegia 25
MX - Messico 24
PL - Polonia 24
SA - Arabia Saudita 23
AR - Argentina 22
PH - Filippine 20
PK - Pakistan 18
AT - Austria 15
CL - Cile 15
IQ - Iraq 15
CI - Costa d'Avorio 14
CZ - Repubblica Ceca 14
ZA - Sudafrica 14
RO - Romania 12
EC - Ecuador 10
JO - Giordania 10
KE - Kenya 10
PE - Perù 10
VE - Venezuela 10
PT - Portogallo 9
TW - Taiwan 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
PY - Paraguay 8
MA - Marocco 7
MY - Malesia 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
IL - Israele 6
TH - Thailandia 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CR - Costa Rica 5
LT - Lituania 5
SC - Seychelles 5
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
LB - Libano 3
LU - Lussemburgo 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
PR - Porto Rico 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
Totale 15.084
Salva come PNG Salva come JPEG
Città #
Southend 1.208
Singapore 737
Shenzhen 465
Chandler 434
Hong Kong 408
Milan 401
Ashburn 370
San Jose 295
Hanover 240
Beijing 234
Seattle 184
Wilmington 164
Dearborn 157
Fairfield 151
Los Angeles 151
Council Bluffs 148
Princeton 140
Frankfurt am Main 126
Ann Arbor 122
Santa Clara 112
Dublin 106
New York 100
Jacksonville 95
Woodbridge 94
Dallas 86
Redmond 84
Houston 81
Nanjing 70
Redwood City 70
Bengaluru 67
Ho Chi Minh City 64
Cambridge 62
Guangzhou 62
Helsinki 59
Buffalo 58
Hanoi 57
Lauterbourg 56
Mountain View 53
Shanghai 52
Seoul 50
Naples 48
Hefei 45
Boardman 44
Toronto 44
Sakarya 43
Des Moines 40
Munich 40
Changsha 39
Rome 38
Berlin 36
Shenyang 35
Jakarta 34
Athens 33
Jinan 33
Moscow 33
Phoenix 32
São Paulo 32
Tokyo 30
Bogotá 29
Napoli 29
Ottawa 29
Andover 28
Brussels 28
Tianjin 28
Cangzhou 27
Kent 25
Columbus 24
Istanbul 24
Serra 24
Fuzhou 22
Hangzhou 22
Nanchang 22
Somerville 22
San Diego 21
Atlanta 20
Montreal 18
The Dalles 18
Washington 17
Bühl 16
Dhaka 16
London 16
Turin 16
Eitensheim 15
Abidjan 14
Albano Sant'Alessandro 14
Fremont 14
Hamburg 14
Sunnyvale 14
Turku 14
Ningbo 13
Nuremberg 13
Quanzhou 13
San Francisco 13
Wuhan 13
Chicago 12
Da Nang 11
Hebei 11
Madison 11
Baghdad 10
Bitonto 10
Totale 9.122
Salva come PNG Salva come JPEG
Nome #
ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease 839
Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin 675
The Enigma of Huntington’s Disease 604
New label-free methods for protein relative quantification applied to the investigation of an animal model of Huntington Disease 508
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease 390
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease 376
Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators 331
Successful sequencing of Huntington’s disease CAG microsatellite orthologs from museum collection specimens 321
Brain-derived neurotrophic factor in patients with Huntington's disease 311
Normal Function of Huntingtin 303
Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease 298
Huntingtin gene and its CAG repeats number in Primates 293
The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities 273
Huntingtin’s neuroprotective activity occurs via inhibition of pro-caspase 9 processing 263
An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin 258
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease 251
Expressed Alu repeats as a novel, reliable tool for normalization of real-time quantitative RT-PCR data 249
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery 248
Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models 247
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target 244
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease 237
Pitfalls in the detection of cholesterol in Huntington’s disease models 237
Brain Regional Identity and Cell Type Specificity Landscape of Human Cortical Organoid Models 229
The function of the neuronal proteins shc and huntingtin in stem cells and neurons - Pharmacologic exploitation for human brain diseases 228
Normal huntingtin function: an alternative approach to Huntington's disease 227
Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease 223
Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death 223
Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease 221
Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons 220
Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease 219
Neuroprotection by ADAM10 inhibition requires TrkB signaling in the Huntington’s disease hippocampus 218
From target identification to drug screening assays for neurodegenerative diseases 215
Brain-derived neurotrophic factor in neurodegenerative diseases 213
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington’s disease patients demonstrates mutation related enhanced lysosomal activity 211
Huntingtin gene CAG repeat size affects autism risk: Family-based and case–control association study 208
Huntington’s disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids 197
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes 190
CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice 188
In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice 186
Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease : restoration by the neuroprotective compound CEP-134 183
Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain 180
Loss of normal huntingtin function: new developments in Huntington's Disease research 179
Role of brain-derived neurotrophic factor in Huntington's disease 178
Shc3 affects human high-grade astrocytomas survival 177
The Huntington's Paradox 174
Huntington's Disease 172
A microRNA-based gene dysregulation pathway in Huntington's disease 170
NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease 170
Geographic differences in the incidence of Huntington’s disease in Sardinia, Italy 169
Comparative expression profiles of ShcB and ShcC phosphotyrosine adapter molecules in the adult brain 164
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease 162
Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors 162
Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes 160
Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop 159
Prevalence of Huntington's disease in Southern Sardinia, Italy 159
Huntingtin-mediated axonal transport requires arginine methylation by PRMT6 159
Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington’s disease neurones 155
The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease 154
Molecular mechanisms and potential therapeutical targets in Huntington's disease 150
Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions 145
The Human Accelerated Region 1 noncoding RNA is repressed by REST in Huntington's disease 139
The link between huntingtin and BDNF and its implication for Huntington's Disease 133
Early transcriptional profiles in huntingtin inducible striatal cells by microarray analyses 124
A human CAGinSTEM platform for decoding HTT repeats’ somatic instability links CAG interruption to HD pathology in neurons 99
Co-localization of brain-derived neurotrophic factor (BDNF) and wild type huntingtin in normal and Quinolinic lesioned rat brain 96
HTT evolution and brain development 92
Early transcriptional profiles in huntingtin-induced striatal cells by microarray analyses 87
Malattia di Huntington: basi biologiche ed approccio medico 83
Huntingtin and its allies at the cortico-striatal synapse 9
Totale 15.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.932
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021288 0 0 0 0 0 0 0 0 0 0 223 65
2021/20221.283 65 60 62 75 121 89 119 94 149 122 115 212
2022/20231.500 222 192 133 208 140 232 27 109 114 25 54 44
2023/20241.243 36 48 517 60 178 30 40 71 23 62 71 107
2024/20252.138 78 186 72 240 172 86 148 234 108 185 154 475
2025/20264.075 333 262 367 291 445 281 672 227 484 293 420 0
Totale 15.715